Palvella Therapeutics Inc. (PVLA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Palvella Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$147.47
+10.95% today
Market cap
$1.9B
Overall quality
—
Kronos AI 30-day
−9.3%
2 of 8 simulated paths end higher
Palvella Therapeutics Inc. (PVLA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.9B. It trades at $147.47, up 10.95% today. 13 analysts' average target of $232.42 implies +57.6% from today's price. Kronos AI's 30-day forecast is −9.3% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $232.42 |
| Low – high | $207.00 – $267.00 |
| Analysts | 13 |
| Upside to average | +57.6% |
Kronos AI 30-day forecast
| Expected close | $120.61 (−9.3%) |
| Likely range | −11.6% … +8.9% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.